Salivary gland carcinoma
MONDO:0000521A carcinoma that arises from the major or minor salivary glands. Representative examples include carcinoma ex pleomorphic adenoma, adenocarcinoma, adenoid cystic carcinoma, and mucoepidermoid carcinoma.
Also known as: salivary gland cancer, carcinoma of saliva-secreting gland, carcinoma of salivary gland, carcinoma of the salivary gland, saliva-secreting gland carcinoma, salivary gland carcinoma, salivary carcinoma
2998 clinical trials for this condition and its sub-types, 26 tagged with Salivary gland carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Salivary gland carcinoma
-
Major salivary gland carcinoma 6 trials
6 sub-types
- Carcinoma of parotid gland 0 trials Sub-types →
- Major salivary gland adenoid cystic carcinoma 0 trials Sub-types →
- Major salivary gland carcinoma ex pleomorphic adenoma 0 trials Sub-types →
- Major salivary gland mucoepidermoid carcinoma 0 trials Sub-types →
- Sublingual gland carcinoma 0 trials Sub-types →
- Submandibular gland cancer 0 trials Sub-types →
-
2 sub-types
- Parotid gland squamous cell carcinoma 0 trials
- Salivary gland adenosquamous carcinoma 0 trials
-
Salivary duct carcinoma 3 trials
-
2 sub-types
-
Mammary analog secretory carcinoma 0 trials
-
Minor salivary gland carcinoma 0 trials
1 sub-type
-
1 sub-type
-
Salivary gland large cell carcinoma 0 trials
-
1 sub-type
-
Salivary gland small cell carcinoma 0 trials
Most studied deeper sub-types
-
Immune cell combo shows promise in tough head and neck cancers
Disease control CompletedThis early-phase trial tested a new approach for people with advanced head and neck cancer that has come back or spread. It combined specially trained natural killer (NK) immune cells with drugs that help the immune system attack cancer. The study enrolled 11 participants to chec…
Phase 1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Could a cancer pill before surgery help head and neck patients?
Disease control CompletedThis early-phase trial tested two doses of the drug erlotinib (Tarceva) given before surgery in 48 people with head and neck cancer. The goal was to see how the drug affects a protein called phospho-Akt in tumor samples. Researchers hope erlotinib might slow tumor growth by block…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 26, 2026 13:40 UTC